Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: New Anti-Smoking Ad Campaign Targets Youth Ruined teeth and damaged skin are among the images being used in a new U.S. government ...
Tags: FDA
February 3, 2014 -- The U.S. Food and Drug Administration today approved the expanded use of the Dexcom G4 Platinum Continuous Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood ...
Tags: FDA
TUESDAY Feb. 4, 2014, 2014 -- U.S. Food and Drug Administration approval of the Dexcom G4 Platinum Continuous Monitoring System has been expanded to include children with diabetes aged 2 years to 17 years, the agency said. Previously ...
Novo Nordisk, a world leader in diabetes care, today announced the launch of the insulin delivery device NovoPen Echo® in the United States. This is the first and only pen device available in the U.S. with half-unit dosing and a memory ...
The holidays are a potentially dangerous time for children with diabetes, an expert warns, and parents need to take steps to keep them safe. "It's extremely important for parents to communicate with their child during the holidays to ...
Biodel, a specialty pharmaceutical company, has announced a long-term supply agreement with Becton, Dickinson and Company, a medical technology company, for worldwide exclusive rights to the novel and proprietary BD Uniject SCF disposable ...
Tags: Biodel, Rescue Device
Denmark-based Novo Nordisk has announced that the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of the NovoRapid PumpCart in Europe. NovoRapid PumpCart is a 1.6ml ...
Denmark-based health care company Novo Nordisk has won US FDA 510(k) clearance for the insulin injection device, NovoPen Echo, combining half-unit dosing with a memory function to help patients manage their diabetes. Available to patients ...
Tags: Insulin Injection, Medicine